VectivBio Holding AG (VECT) Social Stream
VECTIVBIO HOLDING AG (VECT) Price Targets From Analysts
Use the tables below to see what analysts covering VECTIVBIO HOLDING AG think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-24 | 3 | $31 | $17 | $25.333 | $16.85 | 50.34% |
| 2022-04-07 | 3 | $28 | $19 | $23 | $16.85 | 36.5% |
| 2022-04-08 | 3 | $28 | $14 | $21.333 | $16.85 | 26.61% |
| 2022-09-30 | 4 | $28 | $14 | $21.75 | $16.85 | 29.08% |
| 2022-10-13 | 4 | $28 | $21 | $23.5 | $16.85 | 39.47% |
| 2022-10-18 | 4 | $30 | $21 | $24 | $16.85 | 42.43% |
| 2022-10-26 | 5 | $30 | $20 | $23.5 | $16.85 | 39.47% |
| 2023-04-19 | 5 | $30 | $18 | $22.4 | $16.85 | 32.94% |
| 2023-05-10 | 4 | $30 | $18 | $22.8 | $16.85 | 35.31% |
| 2023-05-23 | 2 | $21 | $17 | $18.333 | $16.85 | 8.8% |
The Trend in the Analyst Price Target
Over the past 161 days, VECT's average price target has gone down $4.07.
Over the past 40 weeks, VECT's average upside potential has been 158.24%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-10 | 4 | 28 | 14 | 21.75 | 5.050 | 330.69% |
| 2022-10-18 | 4 | 30 | 21 | 24.00 | 7.360 | 226.09% |
| 2022-12-13 | 5 | 30 | 18 | 22.40 | 8.485 | 164% |
| 2023-02-08 | 5 | 30 | 18 | 22.40 | 8.415 | 166.19% |
| 2023-05-23 | 3 | 21 | 17 | 18.00 | 16.500 | 9.09% |
VECT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.5 | 1 | 0 | 3 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 43 weeks, VECT's average broker recommendation rating worsened by 1.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, VECTIVBIO HOLDING AG's number of analysts covering the stock is greater than 201.91% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, VECTIVBIO HOLDING AG's upside potential (average analyst target price relative to current price) is greater than 368.04% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, VECTIVBIO HOLDING AG's variance in analysts' estimates is lower than -324.31% of them.
- In terms of how VECTIVBIO HOLDING AG fares relative to Healthcare stocks, note that its average analyst price target is greater than 587.14% of that group.
Stocks similar to VECTIVBIO HOLDING AG in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TALS, MOLN, and IPSC.
View All Top Stocks by Price Target
Is VECT a Buy, Hold or Sell? See the POWR Ratings now!